Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Wenshuang Zeng"'
Autor:
Sushan Luo, Qilong Jiang, Wenshuang Zeng, Qinzhou Wang, Zhangyu Zou, Yanyan Yu, Daojun Hong, Quantao Zeng, Song Tan, Zhouao Zhang, Yong Zhang, Xiuming Guo, Jing Chen, Zhongyan Zhao, Shixiong Huang, Jianquan Shi, Ying Chen, Lei Du, Chong Yan, Jianying Xi, Jie Song, Chongbo Zhao, the Chinese Myasthenia Gravis Collaborating Group (CMGCG)
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 11, Iss 8, Pp 2212-2221 (2024)
Abstract Objective Efgartigimod, a neonatal Fc receptor antagonist, facilitates antibody degradation including pathogenic IgGs. The ADAPT study demonstrated the tolerability and efficacy of efgartigimod in the treatment of generalized myasthenia grav
Externí odkaz:
https://doaj.org/article/4ed052dcd6e640d5909d6e1483e6906d
Publikováno v:
Environment International, Vol 190, Iss , Pp 108806- (2024)
Background: Emerging evidence has shown the potential involvement of phthalates (PAEs) exposure in the development of dementia with Lewy bodies (DLB). Metabolomics can reflect endogenous metabolites variation in the progress of disease after chemical
Externí odkaz:
https://doaj.org/article/d8804a0a880d4741a3233f0094c76776
Autor:
Yufan Zhou, Jialin Chen, Zunbo Li, Song Tan, Chong Yan, Sushan Luo, Lei Zhou, Jie Song, Xiao Huan, Ying Wang, Chongbo Zhao, Wenshuang Zeng, Jianying Xi
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
IntroductionAntibodies to MuSK identify a rare subtype of myasthenia gravis (MuSK-MG). In western countries, the onset age of MuSK-MG peaks in the late 30's while it is unknown in Chinese population.MethodsIn this retrospective multicenter study, we
Externí odkaz:
https://doaj.org/article/c1e04e96b0f1401bbcf46bd50f54dceb
Autor:
Haibing Xiao, Wenshuang Zeng, Ling Li, Lina Li, Yuzhen Cui, Jie Wang, Jinhao Ye, Qingyan Yang
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Objective: This study aimed to investigate the efficacy and safety of low-dose rituximab (RTX) in the treatment of neuromyelitis optica spectrum disorders (NMOSD) patients.Methods: NMOSD patients were treated with RTX at ~25% of the standard dose. Th
Externí odkaz:
https://doaj.org/article/603ddbc6a905425eb527b570fffaa33d
Publikováno v:
Open Medicine, Vol 11, Iss 1, Pp 264-269 (2016)
The aim of this meta-analysis was to undertake a meta-analysis to evaluate the correlation between cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) gene rs221775 A>G single nucleotide polymorphism and the susceptibility of multiple sclerosis (MS)
Externí odkaz:
https://doaj.org/article/9383655d607a4e8cb46d4211479e4a47
Publikováno v:
Journal of Neuro-Ophthalmology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f2cf4fc3d7d005d8974e9297d60e114
https://doi.org/10.1097/wno.0000000000001781
https://doi.org/10.1097/wno.0000000000001781
Autor:
Qingyan Yang, Lina Li, Yuzhen Cui, Jie Wang, Ling Li, Haibing Xiao, Wenshuang Zeng, Jinhao Ye
Publikováno v:
Frontiers in Neurology
Frontiers in Neurology, Vol 11 (2020)
Frontiers in Neurology, Vol 11 (2020)
Objective: This study aimed to investigate the efficacy and safety of low-dose rituximab (RTX) in the treatment of neuromyelitis optica spectrum disorders (NMOSD) patients.Methods: NMOSD patients were treated with RTX at ~25% of the standard dose. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56d0b292898955c4d4289d0e49539093
https://doi.org/10.3389/fneur.2020.00642
https://doi.org/10.3389/fneur.2020.00642
Publikováno v:
Neuropathology. 36:485-489
Mutations in the gene encoding caveolin-3 (CAV3) can cause a broad spectrum of clinical phenotypes, including limb girdle muscular dystrophy, rippling muscle disease, distal myopathy (MD), idiopathic persistent elevation of serum creatine kinase and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0823686bf15ef7c48828070cfbc5ed13
https://doi.org/10.1111/neup.12297
https://doi.org/10.1111/neup.12297